HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
Gatanaga
Hiroyuki
H
Yazaki
Hirohisa
H
Tanuma
Junko
J
Honda
Miwako
M
Genka
Ikumi
I
Teruya
Katsuji
K
Tachikawa
Natsuo
N
Kikuchi
Yoshimi
Y
Oka
Shinichi
S
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D015236:HLA-C Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D019829:Nevirapine / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D019380:Anti-HIV Agents; D015236:HLA-C Antigens; C524551:HLA-C*08 antigen; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine